(Q44092356)

29 November 2017

0 references

Ebolavirus: a brief review of novel therapeutic targets (English)

1 reference

29 November 2017

author name string

Andrew S Kondratowicz

series ordinal

1

1 reference

29 November 2017

Wendy J Maury

series ordinal

2

1 reference

29 November 2017

publication date

1 January 2012

1 reference

29 November 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

29 November 2017

volume

7

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

1-4

1 reference

Ebola and marburg hemorrhagic fever

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

21 January 2018

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Recent advances in Ebolavirus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Prospects for immunisation against Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Advanced antisense therapies for postexposure protection against lethal filovirus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Identification of a small-molecule entry inhibitor for filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Inhibition of Ebola virus entry by a C-peptide targeted to endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

A broad-spectrum antiviral targeting entry of enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Development of a broad-spectrum antiviral with activity against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

Antiviral activity of a small-molecule inhibitor of filovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.110

21 January 2018

Identifiers

DOI

10.2217/FMB.11.110

1 reference

29 November 2017

1 reference